The Role of the MAP-Kinase Superfamily in β-Amyloid Toxicity
The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postu...
Saved in:
Published in | Metabolic brain disease Vol. 16; no. 3-4; pp. 175 - 185 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Springer
01.12.2001
|
Subjects | |
Online Access | Get full text |
ISSN | 0885-7490 1573-7365 |
DOI | 10.1023/A:1012541011123 |
Cover
Abstract | The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta-amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta-amyloid. Neuroblastoma (N2alpha) cells were used in all experiments. The cells were exposed to 50, 100, and 500 microM glutamate, and 10, 30, and 50 microM beta-amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2alpha cells with beta-amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta-amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta-amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK. |
---|---|
AbstractList | The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta-amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta-amyloid. Neuroblastoma (N2alpha) cells were used in all experiments. The cells were exposed to 50, 100, and 500 microM glutamate, and 10, 30, and 50 microM beta-amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2alpha cells with beta-amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta-amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta-amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK.The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta-amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta-amyloid. Neuroblastoma (N2alpha) cells were used in all experiments. The cells were exposed to 50, 100, and 500 microM glutamate, and 10, 30, and 50 microM beta-amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2alpha cells with beta-amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta-amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta-amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK. The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta-amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta-amyloid. Neuroblastoma (N2alpha) cells were used in all experiments. The cells were exposed to 50, 100, and 500 microM glutamate, and 10, 30, and 50 microM beta-amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2alpha cells with beta-amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta-amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta-amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK. The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These stimuli include growth factor binding to its receptor as well as stressful situations such as hypoxia and oxidative stress. It has been postulated that one of the mechanisms by which beta -amyloid exerts its toxic effects is to produce oxidative stress. This study therefore investigated whether the MAP-kinase pathway was activated in cells following exposure to beta -amyloid. Neuroblastoma (N2 alpha ) cells were used in all experiments. The cells were exposed to 50, 100, and 500 mu M glutamate, and 10, 30, and 50 mu M beta -amyloid, for 24 h. The methylthiazolyl tetrazolium salt (MTT) assay was performed to determine the degree of toxicity. The generation of hydrogen peroxide was detected by fluorescence microscopy using the dye dihydrochlorofluorescein diacetate (DCDHF). Extracellular-signal-regulated kinase (ERK) and p38 MAP-kinase phosphorylation, as representatives of the MAP-kinase pathway, was determined. Treating N2 alpha cells with beta -amyloid resulted in a greater than 50% reduction in cell viability. These cells also showed a significantly higher presence of hydrogen peroxide. Western Blot analysis revealed that the phosphorylation of p38 MAP kinase was dose-dependently increased in cells exposed to glutamate and beta -amyloid. On the other hand, the phosphorylation of ERK was significantly reduced in these cells. These data therefore suggest that the toxic effects of beta -amyloid involve the generation of hydrogen peroxide, leading to the activation of p38 and the down-regulation of ERK. |
Author | Daniels, Willie M.U. Hendricks, Jacobus Taljaard, Joshua J.F. Salie, Ruduwaan |
Author_xml | – sequence: 1 givenname: Willie M.U. surname: Daniels fullname: Daniels, Willie M.U. – sequence: 2 givenname: Jacobus surname: Hendricks fullname: Hendricks, Jacobus – sequence: 3 givenname: Ruduwaan surname: Salie fullname: Salie, Ruduwaan – sequence: 4 givenname: Joshua J.F. surname: Taljaard fullname: Taljaard, Joshua J.F. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13435455$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11769330$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9LxDAQxYMouq6evUkveqtmkiZtBQ9l8R8qiq7nkE0nGGmbtemC-7X8IH4mu7gqCuJlZg6_92De2ySrjW-QkB2gB0AZPyyOgAITST8BGF8hAxApj1MuxSoZ0CwTcZrkdINshvBEKeUC8nWyAZDKnHM6IMfjR4zufIWRt1HX39fFbXzpGh0wup9NsbW6dtU8ck309hoX9bzyrozG_sUZ1823yJrVVcDt5R6Sh9OT8eg8vro5uxgVV7HhIuliTJmRLM2ESXSG-YRTKzUDmyQTgElugGcGjTXAEEtZJjqnNislSi0k1zTjQ7L_4Ttt_fMMQ6dqFwxWlW7Qz4JKGZe5BPgXhIwLxtMFuLsEZ5MaSzVtXa3bufpMpgf2loAORle21Y1x4ZvjSf-aED0nPjjT-hBatKoPRnfON12rXaWAqkVTqlA_mup1h790X9Z_KN4BZpKRjw |
CODEN | MBDIEE |
CitedBy_id | crossref_primary_10_1016_j_ejphar_2013_11_034 crossref_primary_10_1111_j_1471_4159_2004_02778_x crossref_primary_10_1016_j_yexcr_2005_12_009 crossref_primary_10_1007_BF03033283 crossref_primary_10_1039_c3cp44539a crossref_primary_10_1371_journal_pone_0011820 crossref_primary_10_4303_bda_D110136 crossref_primary_10_1515_revneuro_2018_0008 crossref_primary_10_3389_fncel_2019_00437 crossref_primary_10_3390_ijms21145035 crossref_primary_10_1016_j_neures_2010_10_004 crossref_primary_10_1016_j_neuroscience_2008_02_061 crossref_primary_10_1074_jbc_M610390200 crossref_primary_10_1016_j_neuropharm_2012_07_035 crossref_primary_10_1046_j_1471_4159_2003_01831_x crossref_primary_10_1007_s11011_017_0118_x crossref_primary_10_1016_S0197_4580_03_00126_X crossref_primary_10_1016_j_physbeh_2015_05_029 crossref_primary_10_1111_jnc_12102 crossref_primary_10_1111_j_1745_7254_2005_00158_x crossref_primary_10_1016_j_neuroscience_2010_05_069 crossref_primary_10_1016_j_pneurobio_2004_06_002 crossref_primary_10_1111_j_1365_2990_2004_00569_x crossref_primary_10_1007_s10059_012_2247_8 crossref_primary_10_1196_annals_1332_005 crossref_primary_10_1097_01_jnen_0000235853_70092_ba crossref_primary_10_1371_journal_pone_0286495 crossref_primary_10_3390_biomedicines9010027 crossref_primary_10_1007_s11064_005_6872_x crossref_primary_10_1111_j_1471_4159_2010_06687_x crossref_primary_10_1016_j_neuroscience_2008_08_022 crossref_primary_10_1007_s10616_016_9980_3 crossref_primary_10_1111_j_1440_1681_2012_12000_x crossref_primary_10_4028_www_scientific_net_KEM_288_289_537 crossref_primary_10_1111_j_1471_4159_2007_04869_x |
Cites_doi | 10.1046/j.1471-4159.1999.0731181.x 10.1046/j.1471-4159.1995.65031282.x 10.1016/S0301-0082(99)00042-8 10.1046/j.1471-4159.1998.70052082.x 10.1073/pnas.90.17.7951 10.1074/jbc.273.13.7228 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W 10.1046/j.1460-9568.2000.00164.x 10.1111/j.1600-079X.1998.tb00370.x 10.1016/S0955-0674(97)80061-0 10.1046/j.1471-4159.1999.0722248.x 10.1046/j.1471-4159.1997.69010273.x 10.1016/S0304-3940(00)01229-5 10.1046/j.1471-4159.1995.65041487.x 10.1021/bi990438f 10.1016/S0091-679X(08)61930-5 10.1096/fasebj.9.9.7601337 10.1016/0092-8674(94)90131-7 10.1074/jbc.274.33.23570 10.1016/S0169-328X(00)00025-5 10.1006/jmcc.1999.0959 10.1093/ajcn/71.2.621s 10.1016/S1050-1738(98)00012-7 10.1161/01.RES.83.4.345 10.1016/S0006-8993(97)00043-7 10.1016/S0006-8993(00)02965-6 10.1016/0003-2697(76)90527-3 |
ContentType | Journal Article |
Copyright | 2002 INIST-CNRS |
Copyright_xml | – notice: 2002 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K 7X8 |
DOI | 10.1023/A:1012541011123 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Toxicology Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1573-7365 |
EndPage | 185 |
ExternalDocumentID | 11769330 13435455 10_1023_A_1012541011123 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -Y2 -~C -~X .86 .GJ .VR 06C 06D 0R~ 0VY 123 1N0 1SB 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67N 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYXX AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIVO ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHHG ADHIR ADHKG ADIMF ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU CITATION COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LLZTM M1P M2M M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P PF0 PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 YLTOR Z45 ZMTXR ZOVNA ZXP ~A9 ~EX ~KM IQODW -4W -56 -5G -BR -EM 3V. ADINQ CGR CUY CVF ECM EIF GQ6 NPM Z7U Z83 Z87 Z8O Z8W Z91 7TK 7U7 C1K PUEGO 7X8 |
ID | FETCH-LOGICAL-c354t-e72c62785c4a8e9b30f6a21f44b11b9c138cecfc12eed6d4a90f8d6e6a563a083 |
ISSN | 0885-7490 |
IngestDate | Fri Sep 05 02:46:55 EDT 2025 Fri Sep 05 00:09:02 EDT 2025 Wed Feb 19 02:01:11 EST 2025 Mon Jul 21 09:14:45 EDT 2025 Tue Jul 29 02:13:39 EDT 2025 Thu Apr 24 23:12:03 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3-4 |
Keywords | Human Cell culture Nervous system diseases Extracellular signal-regulated protein kinase Enzyme Pathogenesis Mitogen-activated protein kinase Glutamate Hydrogen Peroxides Cerebral disorder Neuron β Amyloid protein Central nervous system disease Degenerative disease Apoptosis Brain (vertebrata) |
Language | English |
License | https://www.springernature.com/gp/researchers/text-and-data-mining CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c354t-e72c62785c4a8e9b30f6a21f44b11b9c138cecfc12eed6d4a90f8d6e6a563a083 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 11769330 |
PQID | 18352371 |
PQPubID | 23462 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_72369611 proquest_miscellaneous_18352371 pubmed_primary_11769330 pascalfrancis_primary_13435455 crossref_citationtrail_10_1023_A_1012541011123 crossref_primary_10_1023_A_1012541011123 |
PublicationCentury | 2000 |
PublicationDate | 2001-12-01 |
PublicationDateYYYYMMDD | 2001-12-01 |
PublicationDate_xml | – month: 12 year: 2001 text: 2001-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Metabolic brain disease |
PublicationTitleAlternate | Metab Brain Dis |
PublicationYear | 2001 |
Publisher | Springer |
Publisher_xml | – name: Springer |
References | P.W. Conrad (346417_CR6) 1999; 274 M.M. Bradford (346417_CR3) 1976; 71 P.H. Sugden (346417_CR29) 1998; 83 A. Klegeris (346417_CR12) 1997; 49 L. New (346417_CR19) 1998; 8 M.P. Mattson (346417_CR17) 1995; 46 M.J. Robinson (346417_CR23) 1997; 9 F. Mailly (346417_CR15) 1999; 73 R. Seger (346417_CR28) 1995; 9 A. Clerk (346417_CR5) 1998; 273 T. Harkany (346417_CR9) 2000; 12 M. Kurino (346417_CR13) 1995; 65 A. Parpura-Gill (346417_CR22) 1997; 754 T. Satoh (346417_CR26) 2000; 288 X. Huang (346417_CR10) 1999; 38 K. Mielke (346417_CR18) 2000; 61 A.J. Anderson (346417_CR1) 1995; 65 W.M.U. Daniels (346417_CR7) 1998; 24 N.J. Marshall (346417_CR16) 1995; 5 Y. Christen (346417_CR4) 2000; 71 T. Omura (346417_CR20) 1999; 31 S. Samanta (346417_CR25) 1998; 70 C. Behl (346417_CR2) 1994; 77 F.J. Ekinci (346417_CR8) 2000; 76 W.M. Zawada (346417_CR30) 2001; 891 D.T. Loo (346417_CR14) 1993; 90 M.A. Schwarzschild (346417_CR27) 1999; 72 M.A. Pappolla (346417_CR21) 1998; 152 J. Rogers (346417_CR24) 2000; 3 J.N. Keller (346417_CR11) 1997; 69 10438538 - J Biol Chem. 1999 Aug 13;274(33):23570-6 7627094 - Growth Regul. 1995 Jun;5(2):69-84 10759064 - Prog Neurobiol. 2000 May;61(1):45-60 9069255 - Curr Opin Cell Biol. 1997 Apr;9(2):180-6 7601337 - FASEB J. 1995 Jun;9(9):726-35 7541884 - Methods Cell Biol. 1995;46:187-216 14987568 - Trends Cardiovasc Med. 1998 Jul;8(5):220-8 942051 - Anal Biochem. 1976 May 7;72:248-54 8367446 - Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7951-5 10386999 - Biochemistry. 1999 Jun 15;38(24):7609-16 10971616 - Eur J Neurosci. 2000 Aug;12(8):2735-45 10681270 - Am J Clin Nutr. 2000 Feb;71(2):621S-629S 10349832 - J Neurochem. 1999 Jun;72(6):2248-55 10371701 - J Mol Cell Cardiol. 1999 Jun;31(6):1269-79 9721691 - Circ Res. 1998 Aug 24;83(4):345-52 9510431 - J Pineal Res. 1998 Mar;24(2):78-82 10762716 - Brain Res Mol Brain Res. 2000 Mar 29;76(2):389-95 7643105 - J Neurochem. 1995 Sep;65(3):1282-9 10461910 - J Neurochem. 1999 Sep;73(3):1181-8 11164822 - Brain Res. 2001 Feb 9;891(1-2):185-96 7561842 - J Neurochem. 1995 Oct;65(4):1487-98 9272645 - J Neurosci Res. 1997 Jul 15;49(2):229-35 9572294 - J Neurochem. 1998 May;70(5):2082-90 9516415 - J Biol Chem. 1998 Mar 27;273(13):7228-34 9546346 - Am J Pathol. 1998 Apr;152(4):871-7 10876086 - Neurosci Lett. 2000 Jul 14;288(2):163-6 8004671 - Cell. 1994 Jun 17;77(6):817-27 9134960 - Brain Res. 1997 Apr 18;754(1-2):65-71 9202320 - J Neurochem. 1997 Jul;69(1):273-84 |
References_xml | – volume: 73 start-page: 1181 year: 1999 ident: 346417_CR15 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1999.0731181.x – volume: 65 start-page: 1282 year: 1995 ident: 346417_CR13 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1995.65031282.x – volume: 61 start-page: 45 year: 2000 ident: 346417_CR18 publication-title: Prog. Neurobiol. doi: 10.1016/S0301-0082(99)00042-8 – volume: 70 start-page: 2082 year: 1998 ident: 346417_CR25 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1998.70052082.x – volume: 90 start-page: 7951 year: 1993 ident: 346417_CR14 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.90.17.7951 – volume: 273 start-page: 7228 year: 1998 ident: 346417_CR5 publication-title: J. Biol. Chem. doi: 10.1074/jbc.273.13.7228 – volume: 49 start-page: 229 year: 1997 ident: 346417_CR12 publication-title: J. Neurosci. Res. doi: 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W – volume: 12 start-page: 2735 year: 2000 ident: 346417_CR9 publication-title: Eur. J. Neurosci. doi: 10.1046/j.1460-9568.2000.00164.x – volume: 5 start-page: 69 year: 1995 ident: 346417_CR16 publication-title: Growth Reg. – volume: 24 start-page: 78 year: 1998 ident: 346417_CR7 publication-title: J. Pineal Res. doi: 10.1111/j.1600-079X.1998.tb00370.x – volume: 9 start-page: 180 year: 1997 ident: 346417_CR23 publication-title: Curr. Opinion Cell Biol. doi: 10.1016/S0955-0674(97)80061-0 – volume: 72 start-page: 2248 year: 1999 ident: 346417_CR27 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1999.0722248.x – volume: 69 start-page: 273 year: 1997 ident: 346417_CR11 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1997.69010273.x – volume: 288 start-page: 163 year: 2000 ident: 346417_CR26 publication-title: Neurosci. Lett. doi: 10.1016/S0304-3940(00)01229-5 – volume: 65 start-page: 1487 year: 1995 ident: 346417_CR1 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1995.65041487.x – volume: 38 start-page: 7609 year: 1999 ident: 346417_CR10 publication-title: Biochemistry doi: 10.1021/bi990438f – volume: 46 start-page: 187 year: 1995 ident: 346417_CR17 publication-title: Meth. Cell Biol. doi: 10.1016/S0091-679X(08)61930-5 – volume: 9 start-page: 726 year: 1995 ident: 346417_CR28 publication-title: FASEB J. doi: 10.1096/fasebj.9.9.7601337 – volume: 77 start-page: 817 year: 1994 ident: 346417_CR2 publication-title: Cell doi: 10.1016/0092-8674(94)90131-7 – volume: 274 start-page: 23570 year: 1999 ident: 346417_CR6 publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.33.23570 – volume: 76 start-page: 389 year: 2000 ident: 346417_CR8 publication-title: Mol. Brain Res. doi: 10.1016/S0169-328X(00)00025-5 – volume: 31 start-page: 1269 year: 1999 ident: 346417_CR20 publication-title: J. Mol. Cell Cardiol. doi: 10.1006/jmcc.1999.0959 – volume: 152 start-page: 871 year: 1998 ident: 346417_CR21 publication-title: Dis. Am. J. Pathol. – volume: 3 start-page: 38 year: 2000 ident: 346417_CR24 publication-title: Neurosci. News – volume: 71 start-page: 621 issue: Suppl. year: 2000 ident: 346417_CR4 publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/71.2.621s – volume: 8 start-page: 220 year: 1998 ident: 346417_CR19 publication-title: Trends Cardiovasc. Med. doi: 10.1016/S1050-1738(98)00012-7 – volume: 83 start-page: 345 year: 1998 ident: 346417_CR29 publication-title: Circ. Res. doi: 10.1161/01.RES.83.4.345 – volume: 754 start-page: 65 year: 1997 ident: 346417_CR22 publication-title: Brain Res. doi: 10.1016/S0006-8993(97)00043-7 – volume: 891 start-page: 185 year: 2001 ident: 346417_CR30 publication-title: Brain Res. doi: 10.1016/S0006-8993(00)02965-6 – volume: 71 start-page: 248 year: 1976 ident: 346417_CR3 publication-title: Ann. Biochem. doi: 10.1016/0003-2697(76)90527-3 – reference: 9721691 - Circ Res. 1998 Aug 24;83(4):345-52 – reference: 10759064 - Prog Neurobiol. 2000 May;61(1):45-60 – reference: 14987568 - Trends Cardiovasc Med. 1998 Jul;8(5):220-8 – reference: 7601337 - FASEB J. 1995 Jun;9(9):726-35 – reference: 10386999 - Biochemistry. 1999 Jun 15;38(24):7609-16 – reference: 10371701 - J Mol Cell Cardiol. 1999 Jun;31(6):1269-79 – reference: 11164822 - Brain Res. 2001 Feb 9;891(1-2):185-96 – reference: 9272645 - J Neurosci Res. 1997 Jul 15;49(2):229-35 – reference: 942051 - Anal Biochem. 1976 May 7;72:248-54 – reference: 10681270 - Am J Clin Nutr. 2000 Feb;71(2):621S-629S – reference: 7643105 - J Neurochem. 1995 Sep;65(3):1282-9 – reference: 7541884 - Methods Cell Biol. 1995;46:187-216 – reference: 10762716 - Brain Res Mol Brain Res. 2000 Mar 29;76(2):389-95 – reference: 9546346 - Am J Pathol. 1998 Apr;152(4):871-7 – reference: 9516415 - J Biol Chem. 1998 Mar 27;273(13):7228-34 – reference: 10438538 - J Biol Chem. 1999 Aug 13;274(33):23570-6 – reference: 9069255 - Curr Opin Cell Biol. 1997 Apr;9(2):180-6 – reference: 8004671 - Cell. 1994 Jun 17;77(6):817-27 – reference: 10971616 - Eur J Neurosci. 2000 Aug;12(8):2735-45 – reference: 10876086 - Neurosci Lett. 2000 Jul 14;288(2):163-6 – reference: 9202320 - J Neurochem. 1997 Jul;69(1):273-84 – reference: 7627094 - Growth Regul. 1995 Jun;5(2):69-84 – reference: 9572294 - J Neurochem. 1998 May;70(5):2082-90 – reference: 10349832 - J Neurochem. 1999 Jun;72(6):2248-55 – reference: 10461910 - J Neurochem. 1999 Sep;73(3):1181-8 – reference: 7561842 - J Neurochem. 1995 Oct;65(4):1487-98 – reference: 9134960 - Brain Res. 1997 Apr 18;754(1-2):65-71 – reference: 8367446 - Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7951-5 – reference: 9510431 - J Pineal Res. 1998 Mar;24(2):78-82 |
SSID | ssj0003519 |
Score | 1.7915341 |
Snippet | The mitogen-activated protein kinase (MAP kinase) pathway participates in a number of reactions of the cell when responding to various external stimuli. These... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 175 |
SubjectTerms | Alzheimer Disease - etiology Alzheimer Disease - metabolism Amyloid beta-Peptides - metabolism Amyloid beta-Peptides - toxicity Biological and medical sciences Blotting, Western Coloring Agents Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dose-Response Relationship, Drug extracellular signal-regulated kinase Hydrogen Peroxide - metabolism In Vitro Techniques MAP Kinase Signaling System - drug effects Medical sciences Mitogen-Activated Protein Kinases - metabolism Neuroblastoma - enzymology Neuroblastoma - metabolism Neurology p38 Mitogen-Activated Protein Kinases Phosphorylation Tetrazolium Salts Thiazoles Tropical medicine Tumor Cells, Cultured |
Title | The Role of the MAP-Kinase Superfamily in β-Amyloid Toxicity |
URI | https://www.ncbi.nlm.nih.gov/pubmed/11769330 https://www.proquest.com/docview/18352371 https://www.proquest.com/docview/72369611 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bitswEBXtLpRCKb03vaR-aKEQHCz5_uhNXDbpJizZBPJmZFmipq0TNjYt_ax-SL-pI8uXOG3o5UUEo1iJ5mh0RjOaQeg1SwybCcZ1ZglThx3K0Knnxjp2jUSQODE9VgbIzp3zlTVd2-v2VKm8XZLHQ_btt_dK_keq8AzkKm_J_oNkm5fCA_gM8oUWJAztX8u4Dg-UBHIWXOof0ww2psGu2PLr6vQiBQGPwjdnRKefwT5PEyCcX1OW5h2X7oznAAiZ8zqWZSMOXTfjYD4JVaBfeUYDow0HqwYV4Xy8mIzeX6nIW7aJi4asXwUXkzLmclEkxRfawnEZXEyDYDGuPBEfCjqYDqtQ4_ogAh8EddQHkR0FZuuupcqBNtrW2UNVfcNHKU-saqhU-zBWpXx-UfH7qSaAnVnQAmc02_2s9uEfbHNN8CE2gSJatn0TnRIXCBcoQXfdWOnSs-or00P9-IN8UHtDdqjMnS3dwaoSqhzKcXul5C3Le-huZXBogULPfXSDZw_QrVkVUvEQSRBpEkTaRmgAIq0FkbYHIi3NtB_fawBpNYAeodW7cDk616uaGjqDP53r3CXMIa5nM4t63I9NQziUYGFZMcaxzzAsTg6LFxMgT05iUd8QXuJwh9qOSYGvP0Yn2SbjT5HGY-bL9G6-ByTW5sLnxHAIE1aCHZv5vIeG9fRErEo4L-uefIrKwAdiRkHUmc8eett8YatyrRzv2u_Md9u_Em4PvaoFEIHClF4wmvFNsYuwtDlMFx_v4RJZ5BJDjydKcu3bsSwdahrP_jT8c3S7XSIv0El-XfCXwF7zuF-irY9Oz8L55eInfhmUnQ |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+the+MAP-kinase+superfamily+in+%CE%B2-amyloid+toxicity&rft.jtitle=Metabolic+brain+disease&rft.au=DANIELS%2C+Willie+M.+U&rft.au=HENDRICKS%2C+Jacobus&rft.au=SALIE%2C+Ruduwaan&rft.au=TALJAARD%2C+Joshua+J.+F&rft.date=2001-12-01&rft.pub=Springer&rft.issn=0885-7490&rft.volume=16&rft.issue=3-4&rft.spage=175&rft.epage=185&rft_id=info:doi/10.1023%2FA%3A1012541011123&rft.externalDBID=n%2Fa&rft.externalDocID=13435455 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-7490&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-7490&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-7490&client=summon |